http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IT-1224223-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fce12609917e6b910132901d75517ab8 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- |
| filingDate | 1987-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1990-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c41ce34ba3726b6e62b625ea6f1f2efa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_deb5d9ec2726726b0383fb7415050cef http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e527271ef914275823257a50f046403 |
| publicationDate | 1990-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | IT-1224223-B |
| titleOfInvention | USE OF A SOMATOTROPINE RELEASE FACTOR ON YOUR OWN OR IN COMBINATION WITH THE FOLLICLE-STIMULATING HORMONE IN THE TREATMENT OF STERILITY |
| abstract | The use of somatotrophin releasing-factor (GRF) to produce a pharmaceutical prepn. for the treatment of infertility, is claimed. the CRF may be e.g. GRF-29, GRF-37, GRF-40, GRF-44 or GRF-NH2-44. The prepn. may be used simultaneously, sequentially or separately with follicle stimulating hormone (FSH). The FSH may be in the form of Menotrophin or Urofollitrophin. |
| priorityDate | 1987-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415731137 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62819 |
Total number of triples: 15.